Trial Profile
Safety and efficacy of switiching from levetiracetam to brivaracetam in patients with difficult-to-treat partial onset epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Brivaracetam (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 03 Feb 2017 New trial record
- 06 Dec 2016 Results presented at the 70th Annual Meeting of the American Epilepsy Society.